Silver Lake Research

Executive Summary

Silver Lake Research is a US-based diagnostics company that develops, manufactures, and markets novel rapid point-of-care test kits leveraging its proprietary EAP™ System for generating highly specific monoclonal antibodies. Founded in 1992 and operating an ISO13485-compliant, FDA-registered facility in Azusa, California, the company focuses on delivering laboratory-grade accuracy and sensitivity in a rapid format. With over three decades of experience in antibodies and diagnostics, Silver Lake Research has established a strong foundation for growth, though it remains private with limited public disclosures. The company's core technology positions it well in the expanding point-of-care testing market, driven by demand for decentralized diagnostics and infectious disease detection. Recent industry trends favoring rapid, accurate testing could accelerate Silver Lake's commercial opportunities, especially if it secures additional FDA clearances or expands its product portfolio. The company's ability to scale manufacturing and form strategic partnerships will be critical to capturing market share and driving revenue growth.

Upcoming Catalysts (preview)

• Q4 2026FDA Clearance for a New Rapid Test55% success
• Q2 2027Strategic Partnership with a Major Distributor40% success
• Q3 2026Expansion of Manufacturing Capacity70% success